Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: A first-line phase II study-Reference-Cited by-同舟云学术

Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: A first-line phase II study

Published:2011-12 Issue:12 Volume:35 Page:823-830
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Fonck Marianne,Brunet Réné,Becouarn Yves,Legoux Jean-Louis,Dauba Jérôme,Cany Laurent,Smith Denis,Auby Dominique,Terrebonne Éric,Traissac Laurent,Mertens Cécile,Soubeyran Pierre,Bellera Carine,Rainfray Muriel,Mathoulin-Pélissier Simone

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference42 articles.

1. Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients;Louvet;J Clin Oncol,2002

2. Launoy G. Incidence du cancer en France–Estimations régionales du cancer de l’estomac 1985–1995. Réseau français du registre des cancers; 1995–2010.

3. Can older cancer patients tolerate chemotherapy? A prospective pilot study;Chen;Cancer,2003

4. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first-line therapy for patients with recurrent or metastatic gastric cancer;Kim;Am J Clin Oncol,2010

5. Perspectives on stomach cancer;Chang;J Korean Med Sci,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of esogastric cancer in older patients;Therapeutic Advances in Medical Oncology;2024-01

2. State of the scientific evidence and recommendations for the management of older patients with gastric cancer;Journal of Geriatric Oncology;2023-11

3. Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature;Cancer Treatment Reviews;2021-11

4. Nutritional interventions in elderly gastrointestinal cancer patients: the evidence from randomized controlled trials;Supportive Care in Cancer;2018-11-09

5. A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status;Pharmacogenetics and Genomics;2018-01